Overview

Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This study is crossover study to evaluate safety and efficacy of lansoprazole in preterm infants with gastroesophageal reflux.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Dexlansoprazole
Lansoprazole